244 related articles for article (PubMed ID: 30348169)
21. Smoking behavior associated upregulation of SERPINB12 promotes proliferation and metastasis via activating WNT signaling in NSCLC.
Zheng HZ; Miao X; Chang J; Zhou H; Zhang JJ; Mo HM; Jia Q
J Cardiothorac Surg; 2024 Mar; 19(1):141. PubMed ID: 38504347
[TBL] [Abstract][Full Text] [Related]
22. Knockdown of MRPL35 promotes cell apoptosis and inhibits cell proliferation in non-small-cell lung cancer.
Zhao C; Chen L; Jin Z; Liu H; Ma C; Zhou H; Xu L; Zhou S; Shi Y; Li W; Chen Y; Dou C; Wang X
BMC Pulm Med; 2023 Dec; 23(1):507. PubMed ID: 38093266
[TBL] [Abstract][Full Text] [Related]
23. Histone Methyltransferases G9a/
Souza BK; Freire NH; Monteiro TS; Herlinger AL; Jaeger M; Dalmolin MGS; de Farias CB; Gregianin L; Brunetto AT; Brunetto AL; Thiele CJ; Roesler R
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894922
[TBL] [Abstract][Full Text] [Related]
24. APC2 is critical for ovarian WNT signalling control, fertility and tumour suppression.
Mohamed NE; Hay T; Reed KR; Smalley MJ; Clarke AR
BMC Cancer; 2019 Jul; 19(1):677. PubMed ID: 31291912
[TBL] [Abstract][Full Text] [Related]
25. ZNF655 is involved in development and progression of non-small-cell lung cancer.
Teng Z; Yao J; Zhu L; Zhao L; Chen G
Life Sci; 2021 Sep; 280():119727. PubMed ID: 34144060
[TBL] [Abstract][Full Text] [Related]
26. An in vivo functional genomics screen of nuclear receptors and their co-regulators identifies FOXA1 as an essential gene in lung tumorigenesis.
Hight SK; Mootz A; Kollipara RK; McMillan E; Yenerall P; Otaki Y; Li LS; Avila K; Peyton M; Rodriguez-Canales J; Mino B; Villalobos P; Girard L; Dospoy P; Larsen J; White MA; Heymach JV; Wistuba II; Kittler R; Minna JD
Neoplasia; 2020 Aug; 22(8):294-310. PubMed ID: 32512502
[TBL] [Abstract][Full Text] [Related]
27. 5-Methylcytosine transferase NSUN2 drives NRF2-mediated ferroptosis resistance in non-small cell lung cancer.
Chen Y; Jiang Z; Zhang C; Zhang L; Chen H; Xiao N; Bai L; Liu H; Wan J
J Biol Chem; 2024 Apr; 300(4):106793. PubMed ID: 38403250
[TBL] [Abstract][Full Text] [Related]
28. Discovery of the First-in-Class G9a/GLP PROTAC Degrader.
Velez J; Han Y; Yim H; Yang P; Deng Z; Park KS; Kabir M; Kaniskan HÜ; Xiong Y; Jin J
J Med Chem; 2024 Apr; 67(8):6397-6409. PubMed ID: 38602846
[TBL] [Abstract][Full Text] [Related]
29. EZH2/G9a interact to mediate drug resistance in non-small-cell lung cancer by regulating the SMAD4/ERK/c-Myc signaling axis.
Zhang Q; Shi Y; Liu S; Yang W; Chen H; Guo N; Sun W; Zhao Y; Ren Y; Ren Y; Jia L; Yang J; Yun Y; Chen G; Wang L; Wu C
Cell Rep; 2024 Feb; 43(2):113714. PubMed ID: 38306271
[TBL] [Abstract][Full Text] [Related]
30. Metformin inhibits human non-small cell lung cancer by regulating AMPK-CEBPB-PDL1 signaling pathway.
Lu T; Li M; Zhao M; Huang Y; Bi G; Liang J; Chen Z; Zheng Y; Xi J; Lin Z; Zhan C; Jiang W; Wang Q; Tan L
Cancer Immunol Immunother; 2022 Jul; 71(7):1733-1746. PubMed ID: 34837101
[TBL] [Abstract][Full Text] [Related]
31. RETRACTED: KDM4A promotes the growth of non-small cell lung cancer by mediating the expression of Myc via DLX5 through the Wnt/β-catenin signaling pathway.
Sun S; Yang F; Zhu Y; Zhang S
Life Sci; 2020 Dec; 262():118508. PubMed ID: 33002480
[TBL] [Abstract][Full Text] [Related]
32. H3K9 methyltransferases and demethylases control lung tumor-propagating cells and lung cancer progression.
Rowbotham SP; Li F; Dost AFM; Louie SM; Marsh BP; Pessina P; Anbarasu CR; Brainson CF; Tuminello SJ; Lieberman A; Ryeom S; Schlaeger TM; Aronow BJ; Watanabe H; Wong KK; Kim CF
Nat Commun; 2018 Nov; 9(1):4559. PubMed ID: 30455465
[TBL] [Abstract][Full Text] [Related]
33. MicroRNAs in non-small cell lung cancer: Gene regulation, impact on cancer cellular processes, and therapeutic potential.
Petrek H; Yu AM
Pharmacol Res Perspect; 2019 Dec; 7(6):e00528. PubMed ID: 31859460
[TBL] [Abstract][Full Text] [Related]
34. Histone H3K9 methyltransferase SETDB1 augments invadopodia formation to promote tumor metastasis.
Ueshima S; Fang J
Oncogene; 2022 Jun; 41(24):3370-3380. PubMed ID: 35546351
[TBL] [Abstract][Full Text] [Related]
35. The histone methyltransferase Wolf-Hirschhorn syndrome candidate 1-like 1 (WHSC1L1) is involved in human carcinogenesis.
Kang D; Cho HS; Toyokawa G; Kogure M; Yamane Y; Iwai Y; Hayami S; Tsunoda T; Field HI; Matsuda K; Neal DE; Ponder BA; Maehara Y; Nakamura Y; Hamamoto R
Genes Chromosomes Cancer; 2013 Feb; 52(2):126-39. PubMed ID: 23011637
[TBL] [Abstract][Full Text] [Related]
36. Knockdown of HDAC10 inhibits POLE2-mediated DNA damage repair in NSCLC cells by increasing SP1 acetylation levels.
Guo H; Ren H; Han K; Li J; Dong Y; Zhao X; Li C
Pulm Pharmacol Ther; 2023 Dec; 83():102250. PubMed ID: 37657752
[TBL] [Abstract][Full Text] [Related]
37. Carcinoembryonic antigen potentiates non-small cell lung cancer progression via PKA-PGC-1ɑ axis.
Lei J; Wu L; Zhang N; Liu X; Zhang J; Kuang L; Chen J; Chen Y; Li D; Li Y
Mol Biomed; 2024 May; 5(1):19. PubMed ID: 38782774
[TBL] [Abstract][Full Text] [Related]
38. Zinc finger protein 263 upregulates interleukin 33 and suppresses autophagy to accelerate the malignant progression of non-small cell lung cancer.
Xu J; Zhou Y; Wang Q; Liu Y; Tang J
Clin Transl Oncol; 2024 Apr; 26(4):924-935. PubMed ID: 37821764
[TBL] [Abstract][Full Text] [Related]
39. FOXF1 promotes tumor vessel normalization and prevents lung cancer progression through FZD4.
Bian F; Goda C; Wang G; Lan YW; Deng Z; Gao W; Acharya A; Reza AA; Gomez-Arroyo J; Merjaneh N; Ren X; Goveia J; Carmeliet P; Kalinichenko VV; Kalin TV
EMBO Mol Med; 2024 May; 16(5):1063-1090. PubMed ID: 38589650
[TBL] [Abstract][Full Text] [Related]
40. Regulatory roles of ACSL5 in the anti-tumor function of palmitic acid (C16:0) via the ERK signaling pathway.
Lv J; Yanting W; Wei S
Eur J Histochem; 2023 Nov; 67(4):. PubMed ID: 37946526
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
